Infection of macaque monkeys with simian immunodeficiency virus: An animal model for neuro-AIDS

Intervirology

Volumn 40, Issue 2-3, 1997, Pages 112-121

  Petry, Harald ^a   Lüke, Wolfgang ^a  

^a GERMAN PRIMATE CENTER   (Germany)

Author keywords

Animal models; Macaque monkeys; Neuro AIDS; Simian immunodeficiency virus

Indexed keywords

CHEMOKINE; CYTOKINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL MODEL; CENTRAL NERVOUS SYSTEM INFECTION; DEMENTIA; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; MACACA; MENINGOENCEPHALITIS; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIMIAN IMMUNODEFICIENCY VIRUS;

ACQUIRED IMMUNODEFICIENCY SYNDROME; AIDS DEMENTIA COMPLEX; ANIMALS; CENTRAL NERVOUS SYSTEM; DISEASE MODELS, ANIMAL; HIV-1; HUMANS; MACACA; MENINGOENCEPHALITIS; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; MACACA; MACACA MULATTA; RNA VIRUSES; SIMIAE; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 2642666486     PISSN: 03005526     EISSN: 14230100     Source Type: Journal    
DOI: 10.1159/000150538     Document Type: Article

References (107)

1. Barre-Sinoussi F, Chermann JC, Rev F, et al: Isolation of a T-lymphotropic retrovirus from a patient al risk for acquired immunodeficiency syndrome (AIDS), Science 1983;220:868-871.
2. Clavel F, Guetard D, Brun-Vezinct F, ct al: Isolation of a new human retrovirus from West African patients with AIDS, Science 1986:233: 343-346.
3. Levy JA: HIV and Pathogenesis of AIDS, Washington, ASM Press, 1994.
4. Kanki PJ, McLane MF, King NW, et al: Serological identification and characterization of a macaque T-lymphotropic retrovirus closely related to HTLV-IIL Science 1985:228:1199-1201.
5. Daniel MD, Letvin NL, King NW, et al: Isolation of T-cell tropic HTLV-III-like retrovirus from macaques, Science 1985:228:1201-1204.
6. Luke W, Fendrich C, Sprenger R, et al: Structural comparison of the external glycoproteins of HIV and SIV, Intervirology 1991:32:198-203.
7. Chakrabati L, Guyadcr M, Alizon M, et al: Sequence of simian immunodeficiency virus from macaque and its relationships to other human and simian retroviruses, Nature 1987: 328:543-547.
8. Hirsch VM, Olmsted RA, Murphey-Corb M, et al: An African primate lentivirus (SIVsmm) closely related to HIV-2. Nature 1989:339: 389-392.
9. Henderson LE, Benveniste RE, Sowder R, et al: Molecular characterization of gag proteins from simian immunodeficiency virus (SlVntne), J Virol 1988:62:2587-2595.
10. Fukasawa M, Miura T, Hasegawa A, et al: Sequence of simian immunodeficiency virus from African green monkey, a new member of the H1V/SIV group, Nature 1988:333:457-461.
11. Baier M, Garber C, Muller C, et al: Complete nucleotide sequence of a simian immunodeficiency virus from African green monkeys: A novel type of intragroup divergence, Virology 1990;176:216-221.
12. Allan JS, Kanda P, Kennedy RC, et al: Isolation and characterization of simian immunodeficiency viruses from two subspecies of African green monkeys, AIDS Res Hum Retroviruses 1990:6:275-285.
13. Formsgaard A, Hirsch VM, Allan JS, Johnson PR: A highly divergent proviral DNA clones of SIV from distinct species of African green monkey, Virology 1991:182:397-402.
14. Tsujimoto H, Hasegawa A, Maki N, et al: Sequence of a novel simian immunodeficiency virus from a wild-caught African mandrill, Nature 1989:341:539-541.
15. Letvin NL, Daniel MD, Schgal PK, et al: Induction of AIDS-like disease in macaque monkeys with T-cell tropic retrovirus STLV-III, Science 1985;230:71-73.
16. Fultz PN, McClure HM, Anderson DC, Switzer WM: Identification and biologic characterization of an acutely lethal variant of simian immunodeficiency virus from sooty manga-beys(SIV/SMM), AIDS Res Hum Retroviruses 1989:5:397-409.
17. Putkoncn P, Kaaya EE, Bottigcr D, et al: Clinical features and predictive markers of disease progression in cynomolgus monkeys experimentally infected with simian immunodeficiency virus, AIDS 1992:6:257-263.
18. Alter HJ, Eichberg JW, Masur H, et al: Transmission of HTLV-III infection from human plasma to chimpanzees: An animal model for AIDS, Science 1984;226:549-552.
19. Stahl-Hcnnig C, Herchenroder O, Nick S, et al: Experimental infection of macaques with HIV-2ben, a novel HIV-2 isolate, AIDS 1990:4:611-617.
20. Li J, Lord CL, Haselline W, et al: Infection of cynomolgus monkeys with a chimeric H1V-I/ SIVmac virus that expresses the HIV-1 envelope glycoproteins, J AIDS 1992:5:639-646.
21. Reimann K, Li J, Veazcy R, et al: A chimeric simian/human immunodeficiency virus expressing a primary patient human immunodeficiency virus type 1 isolate env causes an AIDS-like disease after in vivo passage in rhesus monkeys, J Virol 1996;70:6922-6928.
22. Joag SV, Li Z, Foresman R, et al: Chimeric simian/human immunodeficiency virus that causes progressive loss of CD4 T-cells and AIDS in pig-tailed macaques, J Virol 1996:70: 3189-3197.
23. The European Concerted Action on Macaque Models for AIDS Research: Protection of macaques against simian immunodeficiency virus infection with inactivated vaccines: Comparison of adjuvants, doses and challenge, Vaccine 1995:13:295-300.
24. Berman PW, Gregory TJ, Riddle I, et al: Protection of chimpanzees from infection by HIV-1 after vaccination with recombinant glycoprotein gpl20 but not gpl60. Nature 1990:345: 622-625.
25. Girard M, Kieny MP, Pinter A, et al: Immunization of chimpanzees confers protection against challenge with human immunodeficiency virus, Proc Natl Acad Sci 1991:88:542-546.
26. Luke W, Voss G, Stahl-Hcnnig C, et al: Protection of cynomolgus macaques (Macaca fascia/-laris) against the infection with the human immunodeficiency virus type 2 strain ben (HIV-2ben) by immunization with the virion-derived envelope glycoprotein gp!30. AIDS Res Hum Retroviruses 1993:9:387-394.
27. Luke W, Coulibaly C, Dittmer U, et al: Simian immunodeficiency virus (SIV) gpl30 oligomers protect rhesus macaques (Macaca imilal-la) against the infection with SIVmac32H grown on T-cells or derived ex vivo, Virology 1996;216:444-450.
28. Daniel MD, Kirchhoff F, Czajak SC, et al: Protective efforts of a live attenuated SIV vaccine with a deletion in the ncf gene, Science 1992: 258:1938-1941.
29. Baba TW, Jeong YS, Pcnnick D, et al: Pathoge nicity of live attenuated SIV after mucosal infection of neonatal macaques, Science 1995; 427:1820-1825.
30. Pctry H, Dittmer U, Stahl-Hennig C, et al: Reactivation of human immunodeficiency virus type 2 in macaques after simian immunodeficiency virus SIVmac superinfection, J Virol 1995:69:1564-1574.
31. Janssen RS, Comblath DR, Epstein LG, et al: Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus type I (HIV-1) infection, Neurology 1991:41:778-785.
32. Brew BJ: HIV-l-rclatcd neurological disease, J AIDS 1993:6:10-15.
33. McArthur JC: HIV dementia: 10 years on, J Neurovirol 1996;2:8.
34. Johnson RT: Viral Infections of the Nervous System, New York, Raven Press, 1981.
35. Levy JA: Pathogenesis of human immunodeficiency virus infection, Microbiol Rev 1993;57: 183-289.
36. Resnick L, DiMarzo VF, Schupbach J, et al: Intra-blood-brain-barricr synthesis of HTLV-lll-specific IgG in patients with neurologic symptoms associated with AIDS or AIDS-related complex, N Engl J Med 1985:313:1498-1504.
37. Gonzalez-Scarano F, Nathanson N, Wong PKY: Retroviruses and the nervous system; in Levy JA (ed): The Retroviridac, New York, Plenum Press, 1995. vol 4. pp 409-470.
38. Price RW, Brew B, Sidtis J, et al: The brain in AIDS: Central nervous system HIV I infection and AIDS dementia complex, Science 1988: 239:586-592.
39. Wiley CA, Achim CL: Human immunodeficiency virus encephalitis is the pathological correlate of dementia in acquired immunodeficiency syndrome, Ann Neurol 1994:36:673-676.
40. Masaliah E, Gc N, Morey M, et al: Cortical dendritic pathology in human immunodeficiency virus encephalitis, Lab Invest 1992:66: 28-291.
41. Everall IP, Luthcrt PJ, Lantos PL: Neuronal loss in the frontal cortex in HIV infection, Lancet 1991:337:1119-1121.
42. Kctzler S, Weis S, Haug H, et al: Loss of neurons in the frontal cortex in AIDS brains, Acta Neuropalhol 1990:80:92-94.
43. Glass JD, Fedor H, Wessclingh SL, et al: 1m-munocytochemical quantitation of human immunodeficiency virus in brain: Correlations with dementia, Ann Neurol 1995:38:755-762.
44. Rao C, Anzili AP, Shcr JH: The neuropathology of AIDS: A review, Adv Neuroimmunol 1993;3:1-15.
45. Epstein LG, Sharer LR, Clio ES, et al: HTLV-111/LAV-likc retrovirus particles in the brains of patients with AIDS encephalopathy, AIDS Res 1985:1:447-496.
46. Koenig S, Gcndclman HE, Orcnstcin JM, et al: Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy, Science 1986:233:1089-1093.
47. Gyorkey F, Melnick JL, Gyorkey P: Human immunodeficiency virus in brain biopsies of patients, J Infect Dis 1987:155:870-876.
48. Paxton WA, Dragic T, Koup R, et al: The p-chemokines, HIV type I second receptors and exposed uninfected persons, AIDS Res Hum Retroviruses 1996:12:1203-1207.
49. Sonnerborg A, Johansson B, Srannegard O: Detection of HIV I DNA and infectious virus in cerebrospinal fluid, AIDS Res Hum Retroviruses 1991;7:369-373.
50. Bell JE, Busutti A, Ironside JW, et al: Human immunodeficiency virus and the brain: Investigation of virus load and neuropathologic changes in pre-AIDS subjects, J Infect Dis 1993:168:818-824.
51. Li Y, Kappes JC, Conway JA, et al: Molecular characterization of human immunodeficiency virus type 1 cloned directly from uninfected brain tissue: Identification of replication-competent and -defective viral genomes, J Virol 1991:65:3973-3985.
52. Moses AV, Bloom FE, Pauza D, et al: Human immunodeficiency virus infection of human brain capillary endothelial cells occurs via a CD4/galactosylccramidc-independent mechanism, Proc Natl Acad Sci USA 1993:90:10474-10478.
53. Nuovo G: In situ detection of polymerase chain reaction-amplified HIV-1 nucleic acids and tumor necrosis factor-a RNA in the central nervous system, Am J Pathol 1994:144:659-666.
54. Muckc L, Masliah E, Campbell IL: Transgenic models to assess the neuropathogenic potential of HIV-1 proteins and cytokines, Curr Top Microbiol Immunol 1995:202:187-192.
55. Toggas SM, Masliah E, Rockenstein EM, et al: Central nervous system damage produced by expression of the HIV-1 coat protein gpl20 in transgenic mice, Nature 1994:367:188-193.
56. Nuovo GJ, Gallary F, MacConnell P, et al: In situ detection of polymerase chain reaction amplified HIV1 nucleic acids and tumor necrosis factor-alpha RNA in the central nervous system, Am J Pathol 1994:144:659-666.
57. Bagasra O, Lavl E, Bobroski L, et al: Cellular reservoirs of HIV-1 in the central nervous system of infected individuals: Identification by the combination of in situ polymerase chain reaction and immunohistochemistry, AIDS 1996:10:573-585.
58. Pulliam L, West D, Haigwood N, et al: HIV-1 envelope gpl20 alters astrocytes in human brain cultures, AIDS Res Hum Retroviruses 1993:9:439-444.
59. Brenneman DE, Westbrook GL, Fulzgerald SP, et al: Neuronal cell killing by the envelope protein of HIV and its prevention by vasoactive intestinal peptide, Nature 1988:335:639-642.
60. Sabatier JM, Vives E, Mabrouk K, et al: Evidence for neurotoxic activity of tat from human immunodeficiency virus type I, J Virol 1991:65:961-967.
61. Kolscn D, Buchhaltcr J, Collman R, et al: HIV-I tat alters normal organization of neurons and astrocytes in primary rodent brain cell cultures: RGD sequence dependence, AIDS Res Hum Retroviruses 1993;9:677-685.
62. Kohleiscn B, Neumann M, Herrmann R, et al: Celluar localization of Ncf expressed in persistently HIV-l-infectcd low-producer astrocytes, AIDS 1992:6:1427-1436.
63. Brack-Wemer R, Klcinschmid! A, Ludvigsen A, et al: Infection of human brain cells by HIV-I: Restricted virus production in chronically infected human glial cell lines, AIDS 1992:6: 273-285.
64. Tomatorc CS, Chandra R, Berger J, et al: Infection of subcortical astrocytes in the pediatric central nervous system, Neurology 1994:44: 481-487.
65. Gallo P, Frei K, Rordorf C, et al: Human immunodeficiency virus type 1 (HIV-1) infection of the central nervous system: Evaluation of cytokines in cerebrospinal fluid, J Immunol 1989:23:109-116.
66. Grimaldi L, Martino G, Franciotta D, et al: Elevated a-nor necrosis factor levels in spinal fluid from HIV-1-infected patients with central nervous system involvement, Ann Neurol 1991:29:21-25.
67. Tyor WR, Glass JD, Griffin JW, et al: Cytokine expression in the brain during the acquired immunodeficiency syndrome, Ann Neurol 1992:31:349-360.
68. Wessclingh S, Glass J, McArthur J, et al: Cytokine dvsrcgulation in HIV-associated neurological disease, Adv Neuroimmunol 1994:4:199-206.
69. Poli G, Brcssler P, Kinter A, et al: Interleukin 4 ir-iuces human immunodeficiency virus expression in infected monocytic cells alone and in synergy with tumor necrosis factor-a by transcriptional and post-transcriptional mechanisms, J Exp Med 1990;172:151-158.
70. Soppcr S, Demuth M, Stahl-Hennig C, ct al: The effect of simian immunodeficiency virus infection in vitro and in vivo on the cytokine production of isolated microglia and peripheral macrophages front rhesus monkey, Virology 1996:220:320-329.
71. Baskin GB, Murphey-Corb M, Roberts ED, et al: Correlates of S1V encephalitis in rhesus monkeys, J Med Primatol 1992:21:59-63.
72. Lackner AA, Smith MO, Munn RJ, et al: Localization of simian immunodeficiency virus in the central nervous system of rhesus monkeys, Am J Pathol 1991;139:609-621.
73. C'hakrabarti L, Hurtrel M, Maairc M, et al: Early viral replication in the brain of SiV- infected rhesus monkeys, Am J Pathol 1991:139:1273-1280.
74. Peluso R, Hasse A, Stowring L, et al: A Trojan horse mechanism for the spread of visna virus in monocytes, Virology 1985:147:231-236.
75. Lackner M, Vogel P, Ramos R, et al: Early events in tissues during infection with pathogenic (SIVntac239) and nonpathogenic (SIV-ntaet all) molecular clones of SIV, Am J Pathol 1994;145:428-439.
76. Desrosiers RC, Hanscn-Moosa A, Mori K, et al: Macrophage-tropic variants ofSIV are associated with specific AIDS-related lesions but are not essential for the development of AIDS, Am J Pathol 1991;139:29-35.
77. Sharma DP, Zink MC, Ardcrson M, et al: Derivation of neurotropic simian immunodeficiency virus from exclusively lymphotropic parental virus: Pathogenesis of infection in macaques, J Virol 1992;66:3550-3556.
78. Narayan O, Stephens EB, Joag SV, et al: Animal models of human immunodeficiency virus neurological disease: in Berger JR, Levy RM (eds): AIDS and the Nervous System, ed 2. Philadelphia, Lippincott-Raven, 1997. pp 123-140.
79. Reimann K, Tenner-Racz K, Racz P, et al: Immunopathogenic events in acute infection of rhesus monkeys with simian immunodeficiency virus of macaques, J Virol 1994:68:2362-2370.
80. Smith MO, Heycs MP, Lackner M: Early intrathecal events in rhesus macaques Macaca imi-laiiaj infected with pathogenic or nonpathogenic molecular clones of simian immunodeficiency virus, Lab Invest 1995;72:547-558.
81. Von Herrsth M, Oldstone MBA, Fox HS: Simian immunodeficiency virus specific CTL in cerebrospinal fluid and brains of SIV-infected rhesus macaques, J Immunol 1995; 154:5582-5589.
82. Hulskottc E, Geretti A, Siebelink K, ct al: Vac-cine-induced virus neutralizing antibodies and cytotoxic cells do not protect macaques from experimental infection with simian immunodeficiency virus S!Vmac32H (J5), J Virol 1995; 69:6289-6296.
83. Jurkicwicz E, Pctrv H, Schaffner J, et al: Localization of a neutralization epitope in the VI-region of the SIVmac251 envelope; in Nornby E, Brown F, Chanock R, Ginsberg H (eds): Modern Approaches to New Vaccines Including Prevention of AIDS, Vaccines 96. New York, Cold Spring Harbor Laboratory Press, 1996. pp 243-248.
84. Lassman H, Sclunicd M, Vase K, et al: Bone marrow derived elements and resident microglia in brain inflammation, Glia 1993:7:19-24.
85. Giulian D, Baker TJ, Shill LN, et al: Interleukin 1 of the central nervous system is produced by ameboid microglia, J Exp Med 1986:164: 594-604.
86. Selmaj ICW, Farooq M, Norton WT, et al: Proliferation of astrocytes in vitro in response to cytokines, a primary role for tumor necrosis factor, J Immunol 1990:144:129-135.
87. Briscoe DM, Cotran RS, Pober JS: Effects of tumor necrosis factor lipopolysaccharide and IL-4 on the expression of vascular cell adhesion molecule 1 in vivo, J Immunol 1992:149:2954-2960.
88. Sassevillc VG, Newman W, Brodic SJ, ct al: Monocyte adhesion to endothelium in simian immunodeficiency virus-induced AIDS-en-ccphalitis is mediated by vascular call adhesion molecule-l/a4pi-inlegrin interactions, Am J Pathol 1994:144:27.
89. Nottct HSLM, Peridskv Y, Sassevilc VG, ct al: Mechanisms for the transendothelial migration of HIV-l-infected monocytes into brain, J Immunol 1996:156:1284-1295.
90. Sassevillc VG, Lackner M: Neuropathogenesis of simian immunodeficiency virus infection in macaque monkeys, J Neurovirol 1997;3:1-9.
91. Furie MB, Randolf GJ: Chemokinesand tissue injury, Am J Pathol 1995:146:1287-1301.
92. Cocchi F, DeVico AL, Garzino-Demo A, et al: Identification of RANTES, MIP-la and i as the major HIV-suppressive factors produced by CD8 T-cells, Science 1995:270:1811-1815.
93. Dragic T, Litwin V, Allaway GP, et al: H1V-I entry' into CD4 cells is mediated by the chemo-kinc receptor CC-CKR-5. Nature 1996:381: 667-673.
94. Schmidtmayerova H, Nottct HSLM, Nuovo G, et al: Human immunodeficiency virus type 1 infection alters chemokine S peptide expression in human monocytes: Implication for recruitment of leucocytes into brain and lymph nodes, Proc Natl Acad Sci USA 1996; 93:700-704.
95. Lackner M: Pathology of simian immunodeficiency virus induced disease: in Letvin NL, Desrosiers RC (eds): Simian Immunodeficiency Virus, Berlin, Springer, 1994. pp 35-64.
96. Cinque P, Marenzi R, Ceresa D: Cytomegalovirus infections of the nervous system, Intervirology 1997:40:85-97.
97. Weber Th, Major EO: Progressive multifocal leukoenccphaiopathy: Molecular biology
98. pathogenesis and clinical impact, intervirology 1997;40:98-111.
99. Berger JR, Concha M: Progressive multifocal leukoenccphaiopathy: The evolution of a disease once considered rare, J Neurovirol 1995: 1:5-18.
100. London WR, Hoult SA, Madden DL, et al: Brain tumors in owl monkeys inoculated with a human polyomavirus (JC virus), Science 1978:201:1246-1249.
101. London WT, Houff SA, McKecver PE, et al: Viral-induced astrocytomas in squirrel monkeys, Prog Clin Biol Res 1983:105:227-237.
102. Akatani K, Imai M, Kimura M: Propagation of JC virus in human neuroblastoma cell line IMR-32. J Med Virol 1994:43:13-19.
103. Malor EO, Miller AE, Mourrain P, et al: Establishment of human glial cells that supports JC virus multiplication, Proc Nall Acad Sci USA 1985:82:1257-1261.
104. Mandl C, Walker DL, Frisque RJ: Derivation and characterization of POJ cells, transformed human fetal glial cells that retain their permissivity for JC virus, J Virol 1987;61: 755-763.
105. Frye S, Trebsl C, Dittmer UEfficient production of JC virus in SVG cells and the use of purified viral antigens for analysis of specific humoral and cellular immune response, J Virol Methods 1997:63:81-92.
106. I Icrchenroder O, Stahl-Hennig C, Luke W, et al: Experimental infection of rhesus monkeys with SIV isolated from African green monkeys, Intcrvirology 1989;30:66-72.
107. Berveniste RE, Morton WR, Clark EA, et al: Inoculation of baboons and macaques with simian immunodeficiency virus/Mne, a primate lentivirus closely related to human immunodeficiency virus type 2. J Virol 1988:62: 2091-2101.